DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Market Report for Catheter Securement Devices 2017 - MedCore" report to their offering.
Manufactured catheter securement devices (MCSDs) were introduced in 1997 to provide superior securement to tape and gauze. These devices are now used for securing the majority of PICCs and a small portion of CVCs, PIVCs and dialysis catheters.
There are numerous studies showing the clinical benefits of the StatLock® device from C. R. Bard, the leading MCSD in the European market, as compared with tape or sutures. It is worth noting that MCSDs that rely on adhesives, such as the StatLock®, lose grip over time and need to be replaced approximately every seven days.
Studies also suggest substantial potential cost savings from using a MCSD when the cost of materials, nursing time and treatment of preventable complications is factored in. Depending on the MCSD and catheter, additional products may be used to stabilize the catheter. Alternatively, catheters are often secured without the use of a MCSD.
For example, transparent dressings are commonly used alone without an MCSD. However, a transparent dressing alone does not anchor the catheter securely against horizontal and lateral forces and is often incorrectly thought of as a securement device. In situations where catheters have a high level of exposure outside the insertion site, tape can be used to secure them.
Key Topics Covered:
Table Of Contents I
List Of Figures Xvii
List Of Charts Xx
European Market For Vascular Access Devices And Accessories Overview
Key Report Updates
3DT Holdings LLC
C. R. Bard
Ivera Medical Corporation
Safety Syringes Inc.
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
For more information about this report visit http://www.researchandmarkets.com/research/nljbhf/european_market